No records found

Date Title Press release Webcast Presentation Other
7 Nov 2008 R&D day presentation November 4/7, 2008 PDF
28 Aug 2008 Corporate information (fact sheet) PDF
16 Apr 2008 Ralfinamide presentation PDF
16 Apr 2008 60th AAN Meeting poster (ralfinamide) PDF
16 Apr 2008 The Nerve Compression and Nerve Entrapment Epidemiology (leaflet) PDF
27 Mar 2008 Media conference - 2007 results PDF
11 Feb 2008 Acquisition of Hunter-Fleming Conference Call PDF
20 Dec 2007 Fact sheet PDF
7 Jun 2007 Safinamide - Abstracts from Movement Disorder Society's 11th International Congress, Istanbul PDF
10 May 2007 Safinamide, a New Anti-Parkinson Agent, is Effective and well-tolerated in Early Parkinson’s Disease PD Patients on a Stable Dose of a Single DA-Agonist: Results of a Randomized, International, Placebo-controlled, Phase III Trial PDF
Half Year Report 2022

Download the Half Year Report 2022 below.

Annual Report 2022

Download the Annual Report 2022 below.